ATE216723T1 - Hormones de croissance humaines mutantes et leur utilisation - Google Patents

Hormones de croissance humaines mutantes et leur utilisation

Info

Publication number
ATE216723T1
ATE216723T1 AT97300902T AT97300902T ATE216723T1 AT E216723 T1 ATE216723 T1 AT E216723T1 AT 97300902 T AT97300902 T AT 97300902T AT 97300902 T AT97300902 T AT 97300902T AT E216723 T1 ATE216723 T1 AT E216723T1
Authority
AT
Austria
Prior art keywords
growth hormone
mutantes
humanes
croissance
hormones
Prior art date
Application number
AT97300902T
Other languages
English (en)
Inventor
Kazuo Chihara
Original Assignee
Japan Chem Res
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=26391431&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE216723(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Japan Chem Res filed Critical Japan Chem Res
Application granted granted Critical
Publication of ATE216723T1 publication Critical patent/ATE216723T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/575—Hormones
    • C07K14/61—Growth hormone [GH], i.e. somatotropin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/12—Growth hormone, growth factor other than t-cell or b-cell growth factor, and growth hormone releasing factor; related peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Farming Of Fish And Shellfish (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AT97300902T 1996-02-13 1997-02-12 Hormones de croissance humaines mutantes et leur utilisation ATE216723T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP5094096 1996-02-13
JP17864396 1996-06-18

Publications (1)

Publication Number Publication Date
ATE216723T1 true ATE216723T1 (de) 2002-05-15

Family

ID=26391431

Family Applications (1)

Application Number Title Priority Date Filing Date
AT97300902T ATE216723T1 (de) 1996-02-13 1997-02-12 Hormones de croissance humaines mutantes et leur utilisation

Country Status (8)

Country Link
US (1) US6238915B1 (de)
EP (1) EP0790305B1 (de)
KR (1) KR980002066A (de)
AT (1) ATE216723T1 (de)
AU (1) AU723494B2 (de)
BR (1) BR9700957A (de)
CA (1) CA2197408A1 (de)
DE (1) DE69712124T2 (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6780613B1 (en) 1988-10-28 2004-08-24 Genentech, Inc. Growth hormone variants
ATE189526T1 (de) 1988-10-28 2000-02-15 Genentech Inc Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
ATE196548T1 (de) 1991-05-10 2000-10-15 Genentech Inc Auswählen von agonisten und antagonisten von liganden
US6506595B2 (en) * 1998-03-31 2003-01-14 Itoham Foods Inc. DNAs encoding new fusion proteins and processes for preparing useful polypeptides through expression of the DNAs
GB0011459D0 (en) * 2000-05-12 2000-06-28 Univ Wales Medicine Sequences
CA2409510A1 (en) * 2000-05-12 2001-11-15 University Of Wales College Of Medicine Method for detecting growth hormone variations in humans, the variations and their uses
MXPA04004291A (es) * 2001-11-09 2004-08-11 Upjohn Co Polimorfismos de un unico nucleotido en la gh-1.
GB0127213D0 (en) * 2001-11-12 2002-01-02 Univ Wales Medicine Method of detecting growth hormone variations in humans the variations and their uses
GB2389115B (en) * 2001-12-14 2005-03-16 Asterion Ltd Polypeptide having a plurality of modified growth hormone receptor binding domains of growth hormone
ES2343518T3 (es) * 2002-09-09 2010-08-03 Hanall Biopharma Co., Ltd. Polipeptidos interferon alfa modificados resistentes a proteasas.
GB0229725D0 (en) * 2002-12-19 2003-01-29 Univ Wales Medicine Haplotype partitioning and growth hormone SNPs
CA2423904A1 (en) * 2002-12-19 2004-06-19 University Of Wales College Of Medicine Haplotype partitioning in the proximal promoter of the human growth hormone (gh1) gene
SE0300959D0 (sv) * 2002-12-19 2003-04-02 Pharmacia Ab Methods for predicting therapeutic response to agents acting on the growth hormone receptor
US7998930B2 (en) 2004-11-04 2011-08-16 Hanall Biopharma Co., Ltd. Modified growth hormones
WO2006121569A2 (en) 2005-04-08 2006-11-16 Neose Technologies, Inc. Compositions and methods for the preparation of protease resistant human growth hormone glycosylation mutants
EP2446898A1 (de) 2010-09-30 2012-05-02 Laboratorios Del. Dr. Esteve, S.A. Verwendung von Wachstumshormonen zur Verbesserung der Immunantwort bei immunsupprimierten Patienten
CN112399851A (zh) 2018-07-11 2021-02-23 俄亥俄大学 基于肽的生长激素作用抑制剂及其使用方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BG49718A3 (en) 1983-07-15 1992-01-15 Bio Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
US5534617A (en) * 1988-10-28 1996-07-09 Genentech, Inc. Human growth hormone variants having greater affinity for human growth hormone receptor at site 1
ATE189526T1 (de) * 1988-10-28 2000-02-15 Genentech Inc Verfahren zum nachweis von aktiven domänen und aminosäureresten in polypeptiden und hormonvarianten
US5350836A (en) * 1989-10-12 1994-09-27 Ohio University Growth hormone antagonists
AU666117B2 (en) * 1991-05-01 1996-02-01 Ohio University Growth hormone antagonists

Also Published As

Publication number Publication date
EP0790305B1 (de) 2002-04-24
BR9700957A (pt) 1998-12-08
DE69712124D1 (de) 2002-05-29
US6238915B1 (en) 2001-05-29
EP0790305A1 (de) 1997-08-20
KR980002066A (ko) 1998-03-30
AU723494B2 (en) 2000-08-31
CA2197408A1 (en) 1997-08-14
AU1266497A (en) 1997-08-21
DE69712124T2 (de) 2002-12-12

Similar Documents

Publication Publication Date Title
DE69712124D1 (de) Hormones de croissance humaines mutantes et leur utilisation
DE59811840D1 (de) Zusammensetzung zur therapie von diabetes mellitus und fettsucht
DE69021263D1 (de) Fibronektinbindungsprotein und dessen Herstellung.
DE69534588D1 (de) Protocadherin-proteine und verwendungen davon
DE69101217T2 (de) Ski mit laufflächenteil, ober Körper und Support für Bindungen.
EP0849361A3 (de) Neue Liganden des Neuropeptide Rezeptors HFGAN72
EP0825996A4 (de) Dem fibroblasten wachstumsfaktor homologer faktor-1(fhf-1) und methoden zu seiner verwendung
AU3062384A (en) Cyclic pentapeptides displaying somatostatin antagonism and method of treatment of mammals therewith
WO2000066730A3 (en) Laminin 2 and methods for its use
HUP9902640A2 (hu) Gliasejtvonal-eredetű neurotróf faktor receptor
WO1994005791A3 (en) Dorsal tissue affecting factor and compositions
HUT66309A (en) Bpc peptides, their preparation and therapeutic use
WO2000053749A3 (en) Vascular adhesion molecules and modulation of their function
DE3853446D1 (de) Fibronectinbindungsprotein und dessen Herstellung.
ES2192199T3 (es) Ligandos de la familia eph biologicamente activos.
DE237398T1 (de) Verfahren zur herstellung biologisch aktiver polypeptide, so erhaltene polypeptide und diese enthaltende zusammensetzungen.
PE20399A1 (es) Muteina ob
DK0977859T3 (da) Den neurotrofiske faktor NNT-1
WO1999031229A3 (en) Peptides and nucleic acids derived from eisenia foetida and the use thereof
WO1999030670A3 (en) Methods of treatment using novel ligands of the neuropeptide receptor hfgan72 and agonists or antagonists thereof
EP0832109A4 (de) Faktor-2, homolog zum fibroblasten-wachstumsfaktor und verfahren zu seiner anwendung
WO2001029084A3 (en) Novel human proteins and polynucleotides encoding the same
DE3869939D1 (de) Biologisch wirksame peptide.
WO2001068693A8 (fr) Nouveau polypeptide, proteine humaine de reception cannabinoide 7, et polynucleotide codant pour ce polypeptide
ATE104344T1 (de) Gereinigte ubiquitin-hydrolase, diese kodierende dns-sequenzen und ihre verwendung zur gewinnung von polypeptiden.

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties